Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Successfully Prices EUR 3 Billion Bond Issue". Paris. 2016-09-06
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Board of Directors Provides Update". Paris. 2016-09-06
Novasep S.A.. (9/6/16). "Press Release: Novasep Appoints Dr. François D’Hooge as Bioconjugation Unit Manager". Lyon. 2016-09-06
TxCell S.A.. (9/5/16). "Press Release: TxCell to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016". Valbonne. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Appoints Allene M. Diaz to Its Board of Directors". Lyon. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Reports Business and Financial Update for the First Half of 2016". Lyon. 2016-09-05
4P-Pharma. (9/1/16). "Press Release: Signature of a License Agreement with 4P-Pharma for the Development of an Anti-cancer Drug". Talence. 2016-09-01
Servier. (9/1/16). "Press Release: Amgen and Servier Extend Omecamtiv Mecarbil Collaboration in Chronic Heart Failure". Thousand Oaks, CA & Suresnes. 2016-09-01
Novasep S.A.. (9/1/16). "Press Release: Demonstration Project Started for the Conversion of Woody Biomass to Chemicals". Brussels. 2016-09-01
bioMérieux S.A.. (8/31/16). "Press Release: bioMérieux – First-Half 2016 Results". Marcy l’Étoile. 2016-08-31
Neovacs S.A.. (8/30/16). "Press Release: Neovacs to Present at Two Major Investor Conferences. The 18th Annual Rodman & Renshaw Global Investment Conference & Bio Europe 2016". Paris & Boston, MA. 2016-08-30
Cerenis Therapeutics S.A.. (8/30/16). "Press Release: Completion of Patient Enrolment in the CARAT Study – Meeting the Clinical Schedule". Toulouse & Ann Arbor, MI. 2016-08-30
TxCell S.A.. (8/24/16). "Press Release: TxCell Appoints Biogen’s Dr. Olivier Danos, Pioneer in Gene Therapy for Neurological Disorders, to Its Scientific Advisory Board". Valbonne. 2016-08-24
Theraclion S.A.. (8/18/16). "Press Release: Strong Interest of Investors in Theraclion – Capital increase Completed @ 100%. Total Amount Raised of €9,7M [Not for UK] 1,7 new shares issued at €5.98 per share". Malakoff. 2016-08-18
TxCell S.A.. (8/3/16). "Press Release: TxCell Announces the Effective Implementation of the Convertible Notes with Warrants (OCABSA) Financing and the Issue of a First Tranche for an Amount of €3 Million in Nominal Value [Not for US, CA, AU, JP]". Valbon 2016-08-03
Sanofi S.A.. (7/29/16). "Press Release: Sanofi Announces Q2 2016 Results". 2016-07-29
Biophytis S.A.. (7/29/16). "Press Release: Biophytis Receives Approval of bpifrance for an Innovation Loan of €1.1M to Finance the SARA-PK Trial". Romainville. 2016-07-29
Nicox S.A.. (7/28/16). "Press Release: Nicox Raises €18 Million to Finance Development of Its Pipeline [Not for distribution in or into the United States of America, Canada, Japan or Australia, except as permitted by applicable law ]". Philadeliphia, PA 2016-07-28
Onxeo S.A.. (7/28/16). "Press Release: Onxeo Reports First-Half 2016 Business Update and Consolidated Financials". Paris & Copenhagen. 2016-07-28
Sanofi S.A.. (7/28/16). "Press Release: Sanofi Receives FDA Approval of Adlyxin for Treatment of Adults with Type 2 Diabetes". Paris. 2016-07-28
Onxeo S.A.. (7/27/16). "Press Release: Onxeo Signs Exclusive License Agreement with Pint Pharma for the Commercialization of Beleodaq in PTCL in South America". Paris & Copenhagen. 2016-07-27
TxCell S.A.. (7/27/16). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2016". Valbonne. 2016-07-27
Novacyt S.A.. (7/20/16). "Press Release: Novacyt Half Year 2016 Revenues. Continued Strong Growth in Novaprep Sales – Strong Growth from the Acquisition of Primerdesign". Paris & Cambridge. 2016-07-20
Genomic Vision S.A.. (7/20/16). "Press Release: Genomic Vision Is Accelerating Its Clinical Trial in Cervical Cancer with an Additional Study in the Czech Republic". Bagneux. 2016-07-20
Neovacs S.A.. (7/19/16). "Press Release: Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids". Paris, Boston, MA & Port Heueneme, CA. 2016-07-19
Neovacs S.A.. (7/19/16). "Press Release: EUR 8 Million Capital Increase Successfully Completed [Not for distribution, directly or indirectly in the United States, Canada, Australia and Japan] ". Paris, Boston, MA & Port Heueneme, CA. 2016-07-19
bioMérieux S.A.. (7/18/16). "Press Release: bioMérieux – Second-Quarter 2016 Business Review". Marcy l’Étoile. 2016-07-18
Euronext N.V.. (7/18/16). "Press Release: Biotech Pharnext Lists on Alternext to Pursue New Therapies for Alzheimer's. €30.9 Million Raised, Market Capitalization €100.4 Million". Paris. 2016-07-18
Poxel S.A.. (7/18/16). "Press Release: Poxel Closes a €26.5 Million Capital Increase". Lyon. 2016-07-18
Euronext N.V.. (7/13/16). "Press Release: GenSight Biologics Lists on Euronext to Become Europe's First Listed Gene Therapy Company. €40 Million Raised, Market Capitalisation €149 Million". Paris. 2016-07-13
Valneva S.E.. (7/12/16). "Press Release: European Investment Bank Grants Valneva a €25 Million Loan to Fund R&D Activities". Lyon & Luxembourg. 2016-07-12
Blink Biomedical S.A.S.. (7/12/16). "Press Release: Blink Biomedical Announces Close of Series A Funding". Lyon. 2016-07-12
Ipsen S.A.. (7/11/16). "Press Release: David Meek Appointed as Chief Executive Officer of Ipsen". Paris. 2016-07-11
Servier. (7/11/16). "Press Release: Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody". San Diego, CA & Suresnes. 2016-07-11
Global Bioenergies S.A.. (7/11/16). "Press Release: Global Bioenergies, IBN-One and Aspen Enter into Partnership on Isooctane for Specialty Fuels". Èvry & Gothenburg area. 2016-07-11
Biomunex Pharmaceuticals SASU. (7/11/16). "Press Release: Biomunex Presents Novel Data Confirming Optimal Druglike Properties and Activity of BiXAb Antibodies". Paris. 2016-07-11
Omnes Capital S.A.S.. (7/8/16). "Press Release: Horama Raises €4 Million with Omnes Capital, Sham Innovation Santé and GO Capital". Paris. 2016-07-08
Onxeo S.A.. (7/7/16). "Press Release: Onxeo Collaborates with the Royal College of Surgeons in Ireland for Research Program on Beleodaq Derivatives". Paris & Copenhagen. 2016-07-07
Genticel S.A.. (7/6/16). "Press Release: Genticel Appoints Eumedix as Strategic Advisor to Support Company’s Access to Innovative Drug Candidates". Paris & Toulouse. 2016-07-06
Sartorius AG. (7/6/16). "Press Release: Sartorius Stedim Biotech Acquires U.S. Start-up kSep Systems. Transaction to Expand SSB’s Bioprocessing Product Portfolio with Innovative Single-use Centrifuges". Aubagne. 2016-07-06
bioMérieux S.A.. (7/6/16). "Press Release: bioMérieux Enlarges Its Pathogen Identification Capability on VITEK MS". Marcy l’Étoile. 2016-07-06
Sanofi S.A.. (7/5/16). "Press Release: Sanofi and Regeneron Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in Japan". Paris & Tarrytown, NY. 2016-07-05
Sanofi S.A.. (7/5/16). "Press Release: Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information". Paris. 2016-07-05
Nicox S.A.. (7/5/16). "Press Release: Nicox to Transfer Commercial Operations to New Pan-European Ophthalmic Specialty Pharmaceutical Company Led by GHO Capital". Sophia Antipolis. 2016-07-05
OSE Immunotherapeutics S.A.. (7/5/16). "Press Release: OSE Immunotherapeutics Announces Exercise of Option within Global License Agreement with Janssen for Further Clinical Development of FR104 and Potential Commercialisation in Autoimmune Diseases". Par 2016-07-05
Onxeo S.A.. (7/4/16). "Press Release: Onxeo Receives USPTO Notice of Allowance for Key AsiDNA Patent, Extending IP Protection in the U.S. until 2031". Paris & Copenhagen. 2016-07-04
Onxeo S.A.. (6/27/16). "Press Release: Onxeo Advances Development Plan for First-in-class Signal Interfering DNA Compound AsiDNA. Near- and Mid Term Expected Milestones". Paris & Copenhagen. 2016-06-27
Stimunity S.A.S. (6/24/16). "Press Release: Stimunity Received a Non-Dilutive Financing from Scientipôle Initiative". Paris. 2016-06-24
Genticel S.A.. (6/23/16). "Press Release: Genticel Reports 18 Months Interim Analysis of GTL001 Phase 2 Trial in HPV16/18 Infected Women". Paris & Toulouse. 2016-06-23
TxCell S.A.. (6/21/16). "Press Release: TxCell Exercises Option from Weizmann Institute of Science Following Effective Grant of Broad CAR-Treg Patent in Europe". Valbonne. 2016-06-21
TxCell S.A.. (6/17/16). "Press Release: TxCell Implements a New Financing Contract of up to €20 Million in Nominal Value through Convertible Notes with Warrants (OCABSA) [Not for distribution in the Unites States, Canada, Australia and Japan]". Valbonne. 2016-06-17
Servier. (6/17/15). "Press Release: Vect-Horus Announces the Signing of a Scientific Collaboration Agreement with Servier". Marseille. 2016-06-17
Global Bioenergies S.A.. (6/13/16). "Press Release: Global Bioenergies’ Renewable Isobutene Compatible with Chemical Oxidation". Évry. 2016-06-13
ImaBiotech S.A.S.. (6/13/16). "Press Release: Mass Spectrometry Imaging (MSI) Award 2016". Lille. 2016-06-13
Sanofi S.A.. (6/12/16). "Press Release: Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide". Paris. 2016-06-12
Dassault Systèmes S.A.. (6/10/16). "Press Release: Dassault Systèmes Re-affirms Its 2019 Non-IFRS EPS Objective of about €3.50 per share". Vélizy-Villacoublay. 2016-06-10
Ipsen S.A.. (6/9/16). "Press Release: Ipsen Successfully Issues Inaugural €300 Million 7-year Notes [Not for distribution in or into the United States, Canada, Australia or Japan]". Paris. 2016-06-09
Global Bioenergies S.A.. (6/6/16). "Press Release: The Investissements d’Avenir Programme Provides €9 Million Funding to Global Bioenergies and IBN-One, as Part of a Programme Involving Cristal Union and L’Oréal". Evry, Paris & Aulnay-sous-bois. 2016-06-06
Pierre Fabre S.A.. (6/2/16). "Press Release: The »Toulouse Cancer Santé« Foundation and the Pierre Fabre Research Institute Launch an Immuno-Oncology Research Team at the Toulouse Oncopole Campus". Toulouse & Castres. 2016-06-02
Novacyt S.A.. (6/2/16). "Press Release: Novacyt Raises Additional €1.4m and Expands into new Primer Design Facilities". Paris & Cambridge. 2016-06-02
bioMérieux S.A.. (6/1/16). "Press Release: bioMérieux Acquires Hyglos and Expands Its Offering to the Detection of Endotoxins in Pharmaceutical Products". Marcy l’Étoile. 2016-06-01
Eurofins Scientific. (6/1/16). "Press Release: Eurofins Reinforces Its Leading Footprint in Food Testing in France with the Acquisition of Agro-Analyses". 2016-06-01
TxCell S.A.. (6/1/16). "Press Release: TxCell and the Lübeck Institute of Experimental Dermatology Launch Collaboration to Develop CAR-Tregs in Bullous Pemphigoid". Valbonne. 2016-06-01
Ipsen S.A.. (6/1/16). "Press Release: Eugenia Litz Is Appointed as Vice President Investor Relations of Ipsen". Paris. 2016-06-01
bioMérieux S.A.. (5/31/16). "Press Release: bioMérieux and the Lyon Civil Hospitals Strengthen Their Collaboration and Expand Their Partnership to Include Claude Bernard University Lyon 1". Marcy l’Étoile & Lyon. 2016-05-31
DBV Technologies S.A.. (5/31/16). "Press Release: DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy". Montrouge. 2016-05-31
TxCell S.A.. (5/25/16). "Press Release: TxCell Obtains Authorization from European Regulatory Authorities to Restart Ovasave Phase IIb Clinical Trial". Valbonne. 2016-05-25
Diaxonhit S.A.. (5/25/16). "Press Release: Diaxonhit and the University Hospitals of Strasbourg Launch the Central European Laboratory Dedicated to AlloMap Testing". Paris & Strasbourg. 2016-05-25
Sanofi S.A.. (5/23/16). "Press Release: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020". Paris. 2016-05-23
Ipsen S.A.. (5/17/16). "Press Release: Ipsen Partners with IMCB to Advance Understanding and Research of Botulinum Neurotoxin Biology". Paris & Singapore. 2016-05-17
Neovacs S.A.. (5/17/16). "Press Release: Neovacs to Attend ChinaBio Event. May 18 & 19, 2016". Paris & Boston, MA. 2016-05-17
Neovacs S.A.. (5/12/16). "Press Release: Neovacs and Stellar Biotechnologies Sign Joint Venture Agreement to Create Neostell SAS". Paris & Boston, MA. 2016-05-12
Sanofi S.A.. (5/12/16). "Press Release: Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation. Reiterates Commitment to Consummating Transaction". Paris. 2016-05-12
Alizé Pharma S.A.S.. (5/11/16). "Press Release: Alizé Pharma II, a Company of the Alizé Pharma Group, Acquired by Jazz Pharmaceuticals". Lyon. 2016-05-11
Cellectis S.A.. (5/11/16). "Press Release: Cellectis Reports First Quarter 2016 Financial Results. Initiated UCART123 GMP Production Concept". New York, NY. 2016-05-11
Sanofi S.A.. (5/5/16). "Press Release: Sanofi Sends Letter to Medivation’s Board of Directors". Paris. 2016-05-05
Innate Pharma S.A.. (5/4/16). "Press Release: First Quarter 2016 Report. Cash, Cash Equivalents and Financial Instruments of the Company Amounted to €255.8 Million". Marseille. 2016-05-04
Ipsen S.A.. (5/3/16). "Press Release: Oncodesign and Ipsen Enter into a Strategic Partnership in Oncology and Oncodesign Joins Ipsen’s Paris-Saclay Campus". Paris & Dijon. 2016-05-03
Dassault Systèmes S.A.. (5/3/16). "Press Release: European Spallation Source Chose Dassault Systèmes’ 3DExperience Platform to Develop the World’s Leading Neutron Research Center". Vélizy-Villacoublay. 2016-05-03
Sanofi S.A.. (4/28/16). "Press Release: Sanofi Offers to Acquire Medivation for $52.50 per Share in Cash". Paris. 2016-04-28
Servier. (4/27/16). "Press Release: Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have a New Treatment Option as Lonsurf (trifluridine/tipiracil) Receives EU Approval". Suresnes. 2016-04-27
Alizé Pharma S.A.S.. (4/26/16). "Press Release: Alizé Pharma Reports Positive Results from Its Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome". Lyon. 2016-04-26
TxCell S.A.. (4/25/16). "Press Release: TxCell and Ospedale San Raffaele Launch Collaboration for the Development of CAR-Tregs in Lupus Nephritis". Valbonne & Milan. 2016-04-25
TxCell S.A.. (4/25/16). "Press Release: Letter to Shareholders – from Stéphane Boissel, CEO of TxCell April 25, 2016". Valbonne & Milan. 2016-04-25
Dassault Systèmes S.A.. (4/21/16). "Press Release: Dassault Systèmes Reports Q1 Non-IFRS Total Revenues at High End of Guidance and Reaffirms 2016 Financial Objectives". Vélizy-Villacoublay. 2016-04-21
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. 2016-04-20
TxCell S.A.. (4/20/16). "Press Release: Financial Information for the 1st Quarter of 2016". Valbonne. 2016-04-20
PeptiMimesis. (4/20/16). "Press Release: PeptiMimesis Secures €1.2m ($1.4m) from Cap Innov’Est". Strasbourg. 2016-04-20
bioMérieux S.A.. (4/20/16). "Press Release: bioMérieux – First-quarter 2016 Business Review. Solid Growth in Sales, up 11.5% at Constant Exchange Rates and Scope of Consolidation". 2016-04-20
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. 2016-04-19
Nicox S.A.. (4/19/16). "Press Release: Nicox Submits New Drug Application for AC-170 to U.S. FDA". Sophia Antipolis. 2016-04-19
AB Science S.A.. (4/18/16). "Press Release: AB Science Announces the Success of a Private Placement [Not for Distriubution, Publication, Release, Directly or Indirectly, in the United States, Canada, Australia or Japan]". Paris. 2016-04-18
Euronext N.V.. (4/15/16). "Press Release: Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro to Paris Market. Raises €33 Million, Market Capitalisation Totals €190 Million". Paris. 2016-04-15
OSE Pharma S.A.. (4/15/16). "Press Release: OSE Pharma and Effimune Announce the Signing of the Merger Treaty to Create OSE Immunotherapeutics". Paris & Nantes. 2016-04-15
Nicox S.A.. (4/15/16). "Press Release: 2015 Financial Results and Business Update". Sophia Antipolis. 2016-04-15
ImaBiotech S.A.S.. (4/14/16). "Press Release: ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory". Lille & Berkeley, CA. 2016-04-14
GeNeuro S.A.. (4/14/16). "Press Release: GeNeuro Sets Offer Price at €13 per Share [Not for Australia, Canada or Japan]". Geneva. 2016-04-14
Pierre Fabre S.A.. (4/14/16). "Press Release: Pierre Fabre Laboratories Sign a New Partnership with a Biotech Company from the Toulouse Region, VibioSphen, within the Framework of the Open Innovation Program »Nature Open Library«". Labège & Castres. 2016-04-14
Keranova. (4/11/16). "Press Release: Keranova Raises €4m ($4.55m) in Series A Funding. Investment Will Finance Development of Prototypes for New Ophthalmic Surgery Equipment". Saint-Etienne & Lyon. 2016-04-11
bioMérieux S.A.. (4/11/16). "Press Release: bioMérieux and Antwerp University Unveil the Final Results of the First Global Point Prevalence Survey of Antibiotic Use and Resistance Rates in Hospitals". Marcy l’Étoile & Antwerp. 2016-04-11
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top